Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells

Demet Candas-Green(University of California, Davis), Jian Jian Li(University of California System), Kit S. Lam(UC Davis Comprehensive Cancer Center), Omer M. Ozpiskin(University of California, Davis), Di Jing(Central South University), William J. Murphy(University of California Davis Medical Center), Ralph R. Weichselbaum(University of Chicago), Soheila Azghadi(University of California, Davis), Andrew Vaughan(University of California, Davis), Tianyi Gao(University of California, Davis), Arta M. Monjazeb(University of California, Davis), Nian Jiang(Central South University), David J. Grdina(University of Chicago), Tzu‐yin Lin(University of California, Davis), Cheikh Menaa(Lawrence Livermore National Laboratory), Weibing Zhou(Central South University), Lin Liu(University of California, Davis), Lu Zhang(WinnMed), Tao Li(Hunan University), Jie Huang(Menlo School), Aijun Wang(Shriners Hospitals for Children - Northern California), Lun-Quan Sun(Central South University), Bowen Xie(University of California, Davis), Rulong Shen(The Ohio State University), Ji Ming Wang(Center for Cancer Research), Shuli Xia(Johns Hopkins University), Ming Fan(Beijing Institute of Technology), Hong-Wu Chen(University of California, Davis), Chong‐Xian Pan(Harvard University), Colleen Sweeney(University of California, Davis), Yanhong Zhang(Kaiser Permanente Vallejo Medical Center), Gayle E. Woloschak(Northwestern University)
Nature Communications
September 14, 2020
Cited by 146


Related Papers